We are live on ! Find out more
UROV

Urovant Sciences Ltd.
UROV

Delisted

UROV was delisted on the 26th of March, 2021.

Back to rankings

41 hedge funds and large institutions have $99.7M invested in Urovant Sciences Ltd. in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 10

84% more capital invested

Capital invested by funds: $54.2M → $99.7M (+$45.5M)

78% more funds holding

Funds holding: 23 → 41 (+18)

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

Holders
41
Holders Change
+18
Holders Change %
+78.26%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
6
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$9.3M
2
BCM
Beryl Capital Management
California
+$4.36M
3
PCM
Prelude Capital Management
New York
+$3.06M
4
GF
Gabelli Funds
New York
+$2.99M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$9.14M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$5.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.31M
4
PHS
Pekin Hardy Strauss
Illinois
-$4.92M
5
SB
Samsara BioCapital
California
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
GH
26
GAM Holding
Switzerland
$413K +$317K +25,600 New
BlackRock
27
BlackRock
New York
$398K -$579K -46,718 -65%
BFM
28
Boothbay Fund Management
New York
$363K +$279K +22,500 New
VEA
29
Virtus ETF Advisers
New York
$296K +$227K +18,324 New
CSS
30
Cubist Systematic Strategies
Connecticut
$287K +$221K +17,800 New
Morgan Stanley
31
Morgan Stanley
New York
$251K +$193K +15,550 New
SFI
32
Susquehanna Fundamental Investments
Pennsylvania
$245K +$188K +15,202 New
VF
33
Virtu Financial
New York
$239K +$183K +14,792 New
TI
34
Telemetry Investments
New York
$204K +$157K +12,633 New
Two Sigma Advisers
35
Two Sigma Advisers
New York
$195K +$150K +12,100 New
WAM
36
Wolverine Asset Management
Illinois
$71K +$55.1K +4,445 New
CFGS
37
Concourse Financial Group Securities
Alabama
$20K – – –
TRCT
38
Tower Research Capital (TRC)
New York
$10K +$7.91K +638 New
Wells Fargo
39
Wells Fargo
California
$5K -$463K -37,396 -99%
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$5K – – –
Walleye Capital
41
Walleye Capital
New York
$1.93K +$1.48M +119,700 New
BBA
42
Baker Bros. Advisors
New York
– -$9.14M -978,505 Closed
Alyeska Investment Group
43
Alyeska Investment Group
Illinois
– -$5.8M -620,889 Closed
Fidelity Investments
44
Fidelity Investments
Massachusetts
– -$5.31M -568,436 Closed
SB
45
Samsara BioCapital
California
– -$1.47M -157,480 Closed
Renaissance Technologies
46
Renaissance Technologies
New York
– -$537K -57,500 Closed
KCM
47
Kornitzer Capital Management
Kansas
– -$477K -51,100 Closed
VWM
48
Vigilare Wealth Management
Arizona
– -$121K -13,000 Closed
1
2

UROV Hedge Fund Activity: Q4 2020 in Review

41 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Urovant Sciences Ltd. (UROV) for Q4 2020, worth a combined $99.7M — up 84% from $54.2M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new UROV positions and 10 closed out — a net gain of 18 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $9.3M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $9.14M sold.

  • 41 institutional investors held Urovant Sciences Ltd. (UROV) as of Q4 2020, up from 23 in Q3 2020.
  • Funds reported $99.7M of Urovant Sciences Ltd. stock for Q4 2020, up 84% quarter-over-quarter.
  • 28 funds opened new Urovant Sciences Ltd. positions in Q4 2020 and 10 closed out, a net change of +18 holders.
  • The largest Urovant Sciences Ltd. buyer in Q4 2020 was Perceptive Advisors, an estimated $9.3M added.
  • The largest Urovant Sciences Ltd. seller in Q4 2020 was Baker Bros. Advisors, an estimated $9.14M sold.

Based on aggregated 13F filings for Q4 2020.